Abbott to Create Diabetes Management Solutions with Tandem
ICER Raises Pricing Recommendation for COVID-19 Drug Remdesivir
FDA Backs New Effort to Repurpose Drugs As COVID-19 Treatments
Children’s Robitussin, Dimetapp Recalled Due to Overdose Risk
Walmart Acquires Pharmacy Management Capabilities from CareZone
FDA Oks Botox As a Biologic for Pediatric Urology Patients
WHO Halts Hydroxychloroquine Study After Seeing No COVID-19 Benefit
Insulin, GLP-1 RA Combo Improves Blood Sugar Control for Diabetics
AbbVie, Genmab Team Up for Antibody Therapeutics for Cancer
Eli Lilly Starts Phase 3 Study of RA Drug as COVID-19 Treatment
Phase 3 Study Finds Roche’s Acute Myeloid Leukemia Drug Effective
Trulicity Beats Others in Patient Adherence, Real World Data Shows
FDA Rescinds Emergency Use Authorization for COVID-19 Antibody Test
AstraZeneca’s Calquence Shows Improvement in Two Clinical Trials
Steroid Dexamethasone Reduces COVID-19 Deaths, Initial Data Shows
Coalition of AGs Accuse 26 Generic Drug Companies of Price Fixing
Merck Earns Approval for Drug Targeting Hospital-Acquired Infection
AstraZeneca, Accent Therapeutics to Create Novel Cancer Therapies
FDA Reverses Emergency Use Authorization for Hydroxychloroquine
Delayed Generic Drug Entry Cost Medicaid $761M, Study Finds
Phase 3 Trial Finds AbbVie’s Rheumatoid Arthritis Drug Effective
Top COVID-19 Vaccines, Treatments Moving Forward in Clinical Trials
FDA Issues Guidance on Patient Access Requests During COVID-19
Phase 1 Study Starts for Lilly’s Second COVID-19 Antibody Treatment
D-cycloserine Augments Exposure Therapy for SAD, Trial Finds
Clinical Trial Finds Hydroxychloroquine Does Not Prevent COVID-19
Combination Antibody Therapy Reduces Relapsed Multiple Myeloma
Eli Lilly Launches Global Study of COVID-19 Antibody Treatments
Cancer Clinical Trial Enrollment Fell During COVID-19 Pandemic
FDA Approves Eli Lilly’s Tau Pathology Drug For Alzheimer’s
Moderna Doses First Patients in Phase 2 Study of COVID-19 Vaccine
$628M HHS Task Order to Advance Manufacturing of COVID-19 Vaccines
Gilead Reports Remdesivir Helped Moderately Ill COVID-19 Patients
Bristol Myers Squibb Announces Commercial Launch of MS Drug
Antidepressant Ineffective Against Apathy in Alzheimer’s Patients
GSK to Manufacture 1B Doses of COVID-19 Vaccine Adjuvant System
Bristol Myers Squibb Drug Ineffective for Recurrent Glioblastoma
Robust Biosimilars Market Promotes High Savings, Affordability